The new era of adjuvant therapies for melanoma

被引：61
作者：
Eggermont, Alexander M. M. [1 ,2 ]
Robert, Caroline [1 ,2 ]
Ribas, Antoni [3 ]
机构：
[1] Gustave Roussy Comprehens Canc Ctr, Villejuif, France
[2] Univ Paris Saclay, Villejuif, France
[3] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Div Hematol & Oncol, Dept Med, Los Angeles, CA 90024 USA
来源：
NATURE REVIEWS CLINICAL ONCOLOGY | 2018年 / 15卷 / 09期
关键词：
STAGE-III; HIGH-RISK; DABRAFENIB; DISSECTION; TRAMETINIB; IPILIMUMAB; SURVIVAL; TRIAL;
D O I：
10.1038/s41571-018-0048-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
New treatment options for patients with resected stage III melanoma have been established with the publication of the results of four pivotal randomized clinical trials, resulting in three drug approvals, with a forth expected, all within only 4 years. Herein, we put these advances into context.
引用
收藏
页码：535 / 536
页数：2
相关论文
共 10 条
  • [1] Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial
    Amaria, Rodabe N.
    Prieto, Peter A.
    Tetzlaff, Michael T.
    Reuben, Alexandre
    Andrews, Miles C.
    Ross, Merrick J.
    Glitza, Isabella C.
    Cormier, Janice
    Hwu, Wen-Jen
    Tawbi, Hussein A.
    Patel, Sapna P.
    Lee, Jeffrey E.
    Gersbenwaid, Jeffrey E.
    Spencer, Christine N.
    Gopalakrishnan, Vancheswaran
    Bassett, Roland
    Simpson, Lauren
    Mouton, Rosalind
    Hudgens, Courtney W.
    Zhao, Li
    Zhu, Haifeng
    Cooper, Zachary A.
    Wani, Khalida
    Lazar, Alexander
    Hwu, Patrick
    Diab, Adi
    Wong, Michael K.
    McQuade, Jennifer L.
    Royal, Richard
    Lucci, Anthony
    Burton, Elizabeth M.
    Reddy, Sangeetha
    Sharma, Padmanee
    Allison, James
    Futreal, Phillip A.
    Woodman, Scott E.
    Davies, Michael A.
    Wargo, Jennifer A.
    [J]. LANCET ONCOLOGY, 2018, 19 (02) : 181 - 193
  • [2] Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant Therapy
    Eggermont, A. M. M.
    Chiarion-Sileni, V.
    Grob, J. -J.
    Dummer, R.
    Wolchok, J. D.
    Schmidt, H.
    Hamid, O.
    Robert, C.
    Ascierto, P. A.
    Richards, J. M.
    Lebbe, C.
    Ferraresi, V.
    Smylie, M.
    Weber, J. S.
    Maio, M.
    Bastholt, L.
    Mortier, L.
    Thomas, L.
    Tahir, S.
    Hauschild, A.
    Hassel, J. C.
    Hodi, F. S.
    Taitt, C.
    de Pril, V.
    de Schaetzen, G.
    Suciu, S.
    Testori, A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (19) : 1845 - 1855
  • [3] Adjuvant Pembrolizumab versus Placebo in Resected Stage III Melanoma
    Eggermont, Alexander M. M.
    Blank, Christian U.
    Mandala, Mario
    Long, Georgina, V
    Atkinson, Victoria
    Dalle, Stephane
    Haydon, Andrew
    Lichinitser, Mikhail
    Khattak, Adnan
    Carlino, Matteo S.
    Sandhu, Shahneen
    Larkin, James
    Puig, Susana
    Ascierto, Paolo A.
    Rutkowski, Piotr
    Schadendorf, Dirk
    Koornstra, Rutger
    Hernandez-Aya, Leonel
    Maio, Michele
    van den Eertwegh, Alfonsus J. M.
    Grob, Jean-Jacques
    Gutzmer, Ralf
    Jamal, Rahima
    Lorigan, Paul
    Ibrahim, Nageatte
    Marreaud, Sandrine
    van Akkooi, Alexander C. J.
    Suciu, Stefan
    Robert, Caroline
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (19) : 1789 - 1801
  • [4] Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma
    Faries, M. B.
    Thompson, J. F.
    Cochran, A. J.
    Andtbacka, R. H.
    Mozzillo, N.
    Zager, J. S.
    Jahkola, T.
    Bowles, T. L.
    Testori, A.
    Beitsch, P. D.
    Hoekstra, H. J.
    Moncrieff, M.
    Ingvar, C.
    Wouters, M. W. J. M.
    Sabel, M. S.
    Levine, E. A.
    Agnese, D.
    Henderson, M.
    Dummer, R.
    Rossi, C. R.
    Neves, R. I.
    Trocha, S. D.
    Wright, F.
    Byrd, D. R.
    Matter, M.
    Hsueh, E.
    MacKenzie-Ross, A.
    Johnson, D. B.
    Terheyden, P.
    Berger, A. C.
    Huston, T. L.
    Wayne, J. D.
    Smithers, B. M.
    Neuman, H. B.
    Schneebaum, S.
    Gershenwald, J. E.
    Ariyan, C. E.
    Desai, D. C.
    Jacobs, L.
    McMasters, K. M.
    Gesierich, A.
    Hersey, P.
    Bines, S. D.
    Kane, J. M.
    Barth, R. J.
    McKinnon, G.
    Farma, J. M.
    Schultz, E.
    Vidal-Sicart, S.
    Hoefer, R. A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 376 (23) : 2211 - 2222
  • [5] Adjuvant interferon-α for the treatment of high-risk melanoma: An individual patient data meta-analysis
    Ives, Natalie J.
    Suciu, Stefan
    Eggermont, Alexander M. M.
    Kirkwood, John
    Lorigan, Paul
    Markovic, Svetomir N.
    Garbe, Claus
    Wheatley, Keith
    [J]. EUROPEAN JOURNAL OF CANCER, 2017, 82 : 171 - 183
  • [6] Complete lymph node dissection versus no dissection in patients with sentinel lymph node biopsy positive melanoma (DeCOG-SLT): a multicentre, randomised, phase 3 trial
    Leiter, Ulrike
    Stadler, Rudolf
    Mauch, Cornelia
    Hohenberger, Werner
    Brockmeyer, Norbert
    Berking, Carola
    Sunderkoetter, Cord
    Kaatz, Martin
    Schulte, Klaus-Werner
    Lehmann, Percy
    Vogt, Thomas
    Ulrich, Jens
    Herbst, Rudolf
    Gehring, Wolfgang
    Simon, Jan-Christoph
    Keim, Ulrike
    Martus, Peter
    Garbe, Claus
    [J]. LANCET ONCOLOGY, 2016, 17 (06) : 757 - 767
  • [7] Adjuvant Dabrafenib plus Trametinib in Stage III BRAF-Mutated Melanoma
    Long, G. V.
    Hauschild, A.
    Santinami, M.
    Atkinson, V.
    Mandala, M.
    Chiarion-Sileni, V.
    Larkin, J.
    Nyakas, M.
    Dutriaux, C.
    Haydon, A.
    Robert, C.
    Mortier, L.
    Schachter, J.
    Schadendorf, D.
    Lesimple, T.
    Plummer, R.
    Ji, R.
    Zhang, P.
    Mookerjee, B.
    Legos, J.
    Kefford, R.
    Dummer, R.
    Kirkwood, J. M.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (19) : 1813 - 1823
  • [8] Survival of patients with advanced metastatic melanoma: the impact of novel therapies-update 2017
    Ugurel, Selma
    Roehmel, Joachim
    Ascierto, Paolo A.
    Flaherty, Keith T.
    Grob, Jean Jacques
    Hauschild, Axel
    Larkin, James
    Long, Georgina V.
    Lorigan, Paul
    McArthur, Grant A.
    Ribas, Antoni
    Robert, Caroline
    Schadendorf, Dirk
    Garbe, Claus
    [J]. EUROPEAN JOURNAL OF CANCER, 2017, 83 : 247 - 257
  • [9] Risk stratification of sentinel node-positive melanoma patients defines surgical management and adjuvant therapy treatment considerations
    Verver, Danielle
    van Klaveren, David
    van Akkooi, Alexander C. J.
    Rutkowski, Piotr
    Powell, Barry W. E. M.
    Robert, Caroline
    Testori, Alessandro
    van Leeuwen, Barbara L.
    van der Veldt, Astrid A. M.
    Keilholz, Ulrich
    Eggermont, Alexander M. M.
    Verhoef, Cornelis
    Grunhagen, Dirk J.
    [J]. EUROPEAN JOURNAL OF CANCER, 2018, 96 : 25 - 33
  • [10] Adjuvant Nivolumab versus Ipilimumab in Resected Stage III or IV Melanoma
    Weber, J.
    Mandala, M.
    Del Vecchio, M.
    Gogas, H. J.
    Arance, A. M.
    Cowey, C. L.
    Dalle, S.
    Schenker, M.
    Chiarion-Sileni, V.
    Marquez-Rodas, I.
    Grob, J-J.
    Butler, M. O.
    Middleton, M. R.
    Maio, M.
    Atkinson, V.
    Queirolo, P.
    Gonzalez, R.
    Kudchadkar, R. R.
    Smylie, M.
    Meyer, N.
    Mortier, L.
    Atkins, M. B.
    Long, G. V.
    Bhatia, S.
    Lebbe, C.
    Rutkowski, P.
    Yokota, K.
    Yamazaki, N.
    Kim, T. M.
    de Pril, V.
    Sabater, J.
    Qureshi, A.
    Larkin, J.
    Ascierto, P. A.
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2017, 377 (19) : 1824 - 1835
1